Evaluation of decoquinate or lasalocid against coccidiosis from natural exposure in neonatal dairy calves

Use of coccidiostat in mineral salt and study on ovine eimeriosis

Coccidiosis is a serious obstacle to sheep production, which is becoming a limiting factor, especially with regard to lamb production. However, there are few studies on this parasite in the State of Rio Grande do Norte. The aim of this study was to evaluate the action of decoquinate, added to mineral salt, for controlling Eimeria infection in lambs, and to identify which species are infecting sheep in the eastern region of the state. This study was carried out from August 2009 to January 2010, and used 76 animals. These were divided into two treatment groups: one with common mineral salt, and the other with mineral salt enriched with 6% micronized decoquinate. Fecal samples and body weight measurements were taken every 14 days for parasitological diagnosis, weight gain follow-up and quantitative analysis. The study showed that there was a significant difference in OPG only at the 7th collection, but no significant difference in weight gain. The Eimeria species found were E. ahsata. E. crandallis. E. granulosa. E. intrincata. E. ovina. E. faurei. E. ovinoidalis. E. pallida and E. parva. It was concluded that addition of decoquinate to mineral salt gave rise to lower oocyst elimination, thus favoring eimeriosis control in sheep.

Nonrespiratory diseases of stocker cattle

Bovine respiratory disease is the most common health issue affecting stocker cattle. There are several nonrespiratory diseases that affect stockers. The more common diseases include rumen tympany, infectious bovine keratoconjunctivitis, coccidiosis, photosensitization, and foot rot. Accurate diagnosis, early treatment, and incorporating appropriate preventive measures can assist cattle production.

Prophylactic use of decoquinate for infections withCryptosporidium parvumin experimentally challenged neonatal calves

OBJECTIVE

To evaluate the effect of daily oral administration of decoquinate to neonatal calves experimentally challenged with various numbers of Cryptosporidium parvum oocysts.

DESIGN

Clinical trial.

ANIMALS

75 calves.

PROCEDURE

Calves were purchased from a commercial dairy during a 5-week period. Calves were housed in individual hutches and fed milk replacer with or without decoquinate (2 mg/kg [0.9 mg/lb per day]). Calves were randomly assigned to treatment and 1 of 5 challenge groups (0, 50, 100, 1000, or 10,000 C. parvum oocysts in 60 mL of saline [0.9% NaCl] solution administered p.o. on the day after arrival). Calves were maintained in the study for as long as 28 days. Calves were clinically assessed for diarrhea and dehydration. Fecal samples were submitted for oocyst enumeration 3 times each week.

RESULTS

Treatment did not affect number of days to first watery feces (diarrhea), number of days to first oocyst shedding, or duration of diarrhea or oocyst shedding. Duration of oocyst shedding was significantly associated with challenge dose of oocysts administered to calves and number of days to first oocyst shedding. Duration of diarrhea and number of days to first oocyst shedding were significantly associated with week of arrival and number of days to first watery diarrhea.

CONCLUSIONS AND CLINICAL RELEVANCE

Daily treatment with decoquinate at the dosage used in this study did not affect oocyst shedding or clinical signs associated with cryptosporidiosis. However, there was an indication that if the number of oocysts calves received could be reduced, then the duration of oocyst shedding and, hence, environmental loading of C. parvum oocysts could be reduced.

Effects of lasalocid in milk replacer of calf starter on health and performance of calves challenged with Eimeria species

Holstein bull calves (n = 48) were purchased from local sale barns at 3 to 7 d of age and were assigned randomly to a 2 x 2 factorial arrangement of lasalocid in milk replacer (0 or 80 mg/kg) and in calf starter (3 or 44 mg/kg of dry matter). On d 10 after arrival, calves were orally dosed with 100,000 Eimeria oocysts. Intakes of calf starter and milk replacer, body weight (BW), BW gain, excretion of fecal oocysts, and fecal scores were determined. Calves fed lasalocid in milk replacer consumed more calf starter, had greater BW gain, shed fewer oocysts in feces, and scoured less frequently and less severely than did calves fed no lasalocid or those fed lasalocid in calf starter alone. The combination of lasalocid in milk replacer and in calf starter did not improve performance above that of calves fed lasalocid in milk replacer alone. Low intake of calf starter prior to weaning may provide an insufficient amount of lasalocid to control effectively the effects of coccidiosis when calves are infected with Eimeria at an early age. Use of coccidiostats in milk replacers may reduce the effects of coccidiosis in young calves that are infected with Eimeria at an early age.

Efficacy of lasalocid and decoquinate against coccidiosis in naturally infected dairy calves

A 56-d growth study compared the effects of lasalocid and decoquinate, or a combination of the two, on rate of gain and control of naturally occurring coccidiosis in weaned Holstein calves. Sixty-four calves (mean BW of 188 kg; age 16 wk) were blocked by BW and degree of oocyst shedding and assigned randomly to one of four treatments with 4 calves per pen and 4 pens per treatment. Treatment groups included an unmedicated control group, lasalocid at 1 mg/kg of BW, decoquinate at .5 mg/kg of BW, or lasalocid plus decoquinate. For the combination treatment, decoquinate was fed at the recommended rate for 28 d, followed by lasalocid for the remaining 28 d of the study. Diets were based on dry-rolled corn and haylage and were fed once daily for ad libitum feed consumption. Calves were weighed weekly, and feces were collected for quantitation of oocyst shedding. Oocyst shedding was low, and clinical coccidiosis was not observed. However, unmedicated calves shed oocysts at a higher rate than medicated calves. Small differences were found among treatments on overall rate of gain and gain efficiency. There was little advantage in gain or performance when calves with subclinical coccidiosis were medicated with anticoccidial agents.

Predicting body weight and wither height in Holstein heifers using body measurements

Relationships between body weight, wither height, and various other body traits, including heart girth, body length, and hip width, were studied using data from six experiments with 2625 observations. Body weight and wither height were regressed on the other body traits. Regressions of body weight including the linear, quadratic, and cubic effects of a single independent variable (heart girth, wither height, hip width or body length) indicated that each measurement would be useful in predicting body weight (R2 > .95); the regression of body weight on heart girth had the highest R2, followed by hip width. Similarly, regressions of wither height on heart girth, wither height, hip width, or body length, including linear, quadratic, and cubic effects, yielded R2 > .99. Regressions considering multiple traits as independent variables showed that the addition of a second body trait added little to the already high multiple correlations found with a single variable. In management situations for which body weight or wither height cannot be measured, various other traits can be used to estimate these body measurements accurately.